Showing 1 - 10 of 19
Objective: Several EU countries are determining reimbursement prices of pharmaceuticals by cross-referencing prices of … direct and indirect impact of a price change depends mainly on the method applied to set reimbursement prices. When applying … cross-reference pricing, the reimbursement price is either determined by the lowest of foreign prices (e.g. Portugal), the …
Persistent link: https://www.econbiz.de/10005404742
Persistent link: https://www.econbiz.de/10005404743
This article reviews policies on physician payment methods that Organisation for Economic Cooperation and Development (OECD) countries have implemented to promote an efficient deployment of physicians. Countries
Persistent link: https://www.econbiz.de/10005404754
Persistent link: https://www.econbiz.de/10005404755
Persistent link: https://www.econbiz.de/10005404758
its current drug reimbursement process because of budgetary constraints. One method of achieving this is to implement a … importance in the decision making around drug reimbursement. Second, a set of priority treatments to be assessed was determined …. Once the treatments eligible for reimbursement were determined, scores were assigned to these treatments according to their …
Persistent link: https://www.econbiz.de/10011005062
reimbursement and pricing of approved drugs, the so-called fourth and fifth hurdles. Methods: We reviewed 38 National Institute for … approved. Thirdly, we considered whether and when each drug was recommended for reimbursement and use by NICE, and whether … conditions of reimbursement applied. Fourthly, for the subset of FDA-approved drugs, we examined formulary placement, cost …
Persistent link: https://www.econbiz.de/10005590240
Persistent link: https://www.econbiz.de/10005590250
-shifting debate affects and is affected by Medicare. The aim is to gain a better understanding of how changes in reimbursement by …
Persistent link: https://www.econbiz.de/10005590262
Payment incentives to both consumers and providers have significant consequences for the equity and efficiency of a healthcare system, and have recently come to the fore in health policy reforms. This review first discusses the economic rationale for the apparent international convergence toward...
Persistent link: https://www.econbiz.de/10005448949